Literature DB >> 21842249

p53 codon 72 polymorphism and recurrent pregnancy loss: a meta-analysis.

Wenru Tang1, Xuhong Zhou, Ying Chan, Xiaomin Wu, Ying Luo.   

Abstract

BACKGROUND: Arg72Pro polymorphism of the p53 tumour suppressor gene have been associated with recurrent pregnancy loss. However, results were inconsistent. We performed this metaanalysis to drive amore precise estimation of association between p53 codon 72 polymorphism and recurrent pregnancy loss.
METHODS: Electronic searche of PubMed was conducted to select studies. Case-control studies containing available genotype frequencies of Arg72Pro were chose, and Odds ratio (OR) with 95% confidence interval (CI) was used to assess the strength of this association.
RESULTS: 4 case-control studies including 523 cases and 378controls were identified. This meta-analysis showed that individuals with the homozygous Pro/Pro genotype had increased risk of recurrent pregnancy loss (OR = 1.85, 95% CI: 1.078 ~ 3.173, p = 0.025) in the pooled analyses. An symmetric funnel plot, the Egger's test (P = 0.497), and the Begg- test (P = 0.85) were all suggestive of the lack of publication bias.
CONCLUSION: This meta-analysis supports the idea that p53 condon72 Pro/Pro genotype is associated with increased risk of recurrent pregnancy loss. To draw comprehensive and true conclusions, further prospective studies with larger numbers of participants worldwide are needed to examine associations between p53 codon 72 polymorphism and recurrent pregnancy loss.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21842249      PMCID: PMC3220438          DOI: 10.1007/s10815-011-9618-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  35 in total

Review 1.  Polymorphic variants in the p53 pathway.

Authors:  M E Murphy
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

2.  Winter temperature and UV are tightly linked to genetic changes in the p53 tumor suppressor pathway in Eastern Asia.

Authors:  Hong Shi; Si-jie Tan; Hua Zhong; Wenwei Hu; Arnold Levine; Chun-jie Xiao; Yi Peng; Xue-bin Qi; Wei-hua Shou; Run-lin Z Ma; Yi Li; Bing Su; Xin Lu
Journal:  Am J Hum Genet       Date:  2009-04-02       Impact factor: 11.025

3.  Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.

Authors:  Ang Yuan; Chong-Jen Yu; Kwen-Tay Luh; Sow-Hsong Kuo; Yung-Chie Lee; Pan-Chyr Yang
Journal:  J Clin Oncol       Date:  2002-02-15       Impact factor: 44.544

4.  Role of p53 codon 72 polymorphism in recurrent pregnancy loss.

Authors:  C B Coulam; C Kay; R S Jeyendran
Journal:  Reprod Biomed Online       Date:  2006-03       Impact factor: 3.828

Review 5.  Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.

Authors:  W P Bennett; S P Hussain; K H Vahakangas; M A Khan; P G Shields; C C Harris
Journal:  J Pathol       Date:  1999-01       Impact factor: 7.996

6.  A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss.

Authors:  F Sata; H Yamada; A Yamada; E H Kato; S Kataoka; Y Saijo; T Kondo; J Tamaki; H Minakami; R Kishi
Journal:  Mol Hum Reprod       Date:  2003-11       Impact factor: 4.025

7.  p53 polymorphic variants at codon 72 exert different effects on cell cycle progression.

Authors:  David Pim; Lawrence Banks
Journal:  Int J Cancer       Date:  2004-01-10       Impact factor: 7.396

8.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.

Authors:  Patrick Dumont; J I-Ju Leu; Anthony C Della Pietra; Donna L George; Maureen Murphy
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

9.  p53 regulates maternal reproduction through LIF.

Authors:  Wenwei Hu; Zhaohui Feng; Angelika K Teresky; Arnold J Levine
Journal:  Nature       Date:  2007-11-29       Impact factor: 49.962

10.  No association of C677T methylenetetrahydrofolate reductase and an endothelial nitric oxide synthase polymorphism with recurrent pregnancy loss.

Authors:  Aiko Makino; Tamao Nakanishi; Mayumi Sugiura-Ogasawara; Yasuhiko Ozaki; Nobuhiro Suzumori; Kaoru Suzumori
Journal:  Am J Reprod Immunol       Date:  2004-07       Impact factor: 3.886

View more
  6 in total

1.  Negative effect of P72 polymorphism on p53 gene in IVF outcome in patients with repeated implantation failure and pregnancy loss.

Authors:  Belén Lledo; Azahara Turienzo; Jose A Ortiz; Ruth Morales; Jorge Ten; Joaquin Llácer; Rafael Bernabeu
Journal:  J Assist Reprod Genet       Date:  2013-12-11       Impact factor: 3.412

2.  The interaction effect of angiogenesis and endothelial dysfunction-related gene variants increases the susceptibility of recurrent pregnancy loss.

Authors:  E A Trifonova; M G Swarovskaya; O A Ganzha; O V Voronkova; T V Gabidulina; V A Stepanov
Journal:  J Assist Reprod Genet       Date:  2019-01-24       Impact factor: 3.412

3.  Association between p53 polymorphism at codon 72 and recurrent spontaneous abortion.

Authors:  Ying Zhang; Yuan-Yuan Wu; Fu-Yuan Qiao; Wan-Jiang Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

4.  Genetics of recurrent miscarriage: challenges, current knowledge, future directions.

Authors:  Kristiina Rull; Liina Nagirnaja; Maris Laan
Journal:  Front Genet       Date:  2012-03-19       Impact factor: 4.599

5.  Increased apoptosis rate of human decidual cells and cytotrophoblasts in patients with recurrent spontaneous abortion as a result of abnormal expression of CDKN1A and Bax.

Authors:  Xiaomei Lv; Zhenhong Cai; Su Li
Journal:  Exp Ther Med       Date:  2016-09-09       Impact factor: 2.447

6.  Androgen-induced alterations in endometrial proteins crucial in recurrent miscarriages.

Authors:  Tanzil Ur Rahman; Kamran Ullah; Meng-Xi Guo; Hai-Tao Pan; Juan Liu; Jun Ren; Lu-Yang Jin; Yu-Zhong Zhou; Yi Cheng; Jian-Zhong Sheng; He-Feng Huang
Journal:  Oncotarget       Date:  2018-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.